Results 41 to 50 of about 293,480 (309)

The 40-day cytisine treatment for smoking cessation: the Italian experience.

Tobacco Prevention and Cessation, 2017
Introduction In Eastern Europe, cytisine has been used a lot in smoking cessation while in Italy, it has only recently been introduced, however using a longer treatment schedule consisting of 40 days instead of 25 and a different posology.
Maria Sofia Cattaruzza, Vincenzo Zagà, Rosastella Principe, Salvatore Cardellicchio, Licia Siracusano, Giovanni Zelano, Biagio Tinghino   +6 more
doaj   +1 more source

Tobacco smoking and all-cause mortality in a large Australian cohort study: findings from a mature epidemic with current low smoking prevalence [PDF]

, 2015
This study finds that up to two-thirds of deaths in current smokers  in Australia can be attributed to smoking. Abstract Background The smoking epidemic in Australia is characterised by historic levels of prolonged smoking, heavy smoking, very ...
Alan D. Lopez, Bette Liu, Ellie Paige, Emily Banks, Freddy Sitas, Grace Joshy, Marianne F. Weber, Robert Grenfell, Sam Egger, Valerie Beral   +9 more
core   +3 more sources

Incentives for smoking cessation [PDF]

Cochrane Database of Systematic Reviews
Financial incentives (money, vouchers, or self-deposits) can be used to positively reinforce smoking cessation. They may be used as one-off rewards, or in various schedules to reward steps towards sustained smoking abstinence (known as contingency management).
Notley, Caitlin, Gentry, Sarah, Livingstone-Banks, Jonathan, Bauld, Linda, Perera, Rafael, Conde, Monserrat, Hartmann-Boyce, Jamie   +6 more
openaire   +4 more sources

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Effects of behavioural activation on substance use and depression: a systematic review

Substance Abuse Treatment, Prevention, and Policy, 2018
Introduction Substance use and depression co-occurrence is a frequent phenomenon and an important public health concern. Given the clinical implications and the high prevalence of both disorders, effective interventions are needed.
Carmela Martínez-Vispo, Úrsula Martínez, Ana López-Durán, Elena Fernández del Río, Elisardo Becoña   +4 more
doaj   +1 more source

A survey of UK optometry trainees' smoking cessation training [PDF]

, 2016
BACKGROUND: Smoking is a risk factor for a number of eye conditions, including age-related macular degeneration, cataracts and thyroid eye disease. Smoking cessation interventions have been shown to be highly cost-effective when delivered by a range of ...
Doll R, Lancaster T, Law M, Lenz TL, Richards B, Shahab L, Spafford MM, Stead LF, West R   +8 more
core   +1 more source

Clinical Spectrum and Outcomes of SOX1 Antibody‐Associated Paraneoplastic Neurological Syndromes: A Chinese Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background SOX1 antibody‐positive paraneoplastic neurological syndromes (PNS) exhibit significant population‐specific clinical heterogeneity. While Western cohorts predominantly manifest Lambert‐Eaton myasthenic syndrome (65%–80%), comprehensive clinical characterization and treatment response data in Asian populations remain critically ...
Jin‐Long Ye, Zu‐Ying Kuang, Bo Li, Meng‐Qiu Pan, Li‐Hua Zhou, Yang‐Yang Dai, Si‐Fen Xie, Xian‐Guang Lin, Ye‐Peng Hu, Li‐Hong Jiang, Zhan‐Hang Wang, Wei‐Jing Zhang   +11 more
wiley   +1 more source

How a sample of English stop smoking services and vape shops adapted during the early COVID-19 pandemic: a mixed-methods cross-sectional survey

Harm Reduction Journal, 2021
Background The COVID-19 pandemic in England led to major changes in the delivery of support via stop smoking services (SSS) and to the widespread temporary closure of bricks and mortar e-cigarette retailers (vape shops herein).
Sharon Cox, Emma Ward, Louise Ross, Caitlin Notley   +3 more
doaj   +1 more source

Smoking cessation during pregnancy: the influence of partners, family and friends on quitters and non-quitters [PDF]

, 2010
This research compared pregnant quitters’ and non-quitters’ accounts of how partners, family and friends influenced their smoking cessation attempts.
Aaronson, Acharya, Akhtar, Aveyard, Bursey, Caplan, Carbonari, Carstairs, Casper, Cnattingius, Coppotelli, Delpisheh, Denham, Department of Health, Dunn, Dunn, Edwards, Fingerhut, Ford, Forrest, Foulds, Ginsberg, Glasgow, Harwood, Haslam, Haug, Hoffman, Hyland, Hymowitz, Irwin, Jarvis, Judge, Jun, Kyrklund-Blomberg, Lichtenstein, Lumley, Mallin, Manfredi, McBride, McBride, McBride, McEwen, Medicines and Healthcare Products Regulatory Agency Committee on Safety of Medicines, Mermelstein, Mermelstein, Muhr, Mullen, Nichter, Norman, Ockene, Opp, Park, Park, Penn, Phillips, Pickett, Pollak, Pollak, Prochaska, Quinn, Reno, Rhodes, Rimal, Ritchie, Ruggiero, Russell, Ryan, Schaffer, Severson, Slade, Stotts, Stotts, Suzuki, Tappin, Thompson, Usmani, Van Den Putte, Velicer, Wakefield, Wakschlag, Walsh   +80 more
core   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

Annals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold, Krzysztof W. Selmaj, Regina Berkovich, Jeffrey A. Cohen, Giancarlo Comi, Eva K. Havrdová, James K. Sheffield, Hetal Desai, Chun‐Yen Cheng, Jon V. Riolo, Andrew Thorpe, Erik DeBoer, Bruce A. C. Cree   +12 more
wiley   +1 more source